Grant
DKK 21 million for an interdisciplinary project on new diagnostics
A project involving SDU and OUH has received just under DKK 21 million from Innovation Fund Denmark. The project will develop technology that can make diagnostics for infections, antibiotic resistance and disease both faster and more precise.
The project, called nanoRaman, brings together researchers, clinicians and companies from across the entire value chain. Participants include the University of Southern Denmark (SDU), Odense University Hospital (OUH), DFM Danish Fundamental Metrology at the Technical University of Denmark (DTU) - as well as companies specialising in optics and spectroscopy. Collaboration between research, clinical practice and industry is key to taking the technology all the way from idea to application.
If the project succeeds, it could provide doctors and researchers with a new tool that reduces analysis time in the laboratory and supports decision-making on treatment. The project also aims to improve patient pathways, reduce delays and make better use of healthcare resources.
Research groups from both the Faculty of Health Sciences and the Faculty of Science at SDU, as well as OUH, are involved in the project. The project is part of Innovation Fund Denmark’s Grand Solutions programme.
Collaboration between research and clinical practice drives new diagnostics
SDU contributes advanced microscopy and artificial intelligence, while OUH tests the technology on clinical samples.
– Through two previous EU projects, we have explored the use of Raman spectroscopy for diagnostic purposes together with the project team. It has been exciting but also challenging to collaborate across such different disciplines and across hospital, university and industry, says Thomas Emil Andersen, professor at the Department of Clinical Research and Odense University Hospital.
– But it is when this kind of collaboration succeeds that we can push the boundaries of what is technologically possible and, therefore, diagnostically. In the new project, we are taking an important step forward towards real clinical application.
New technology could provide faster answers
The project will develop a method that can identify signs of disease rapidly and precisely – without the use of dyes or chemical markers. The method is based on Raman spectroscopy, a technology that reads a sample’s chemical ‘fingerprint’ without adding dyes or chemicals.
– At SDU, we will help link the new nanoRaman technology with advanced microscopy and artificial intelligence. This allows us to analyse biological samples without staining and detect changes in the chemical composition and structure of cells. In the long term, it may help provide faster and more precise answers in diagnostics, says Jonathan Brewer, professor and head of Bioimaging at the Department of Biochemistry and Molecular Biology, University of Southern Denmark.
In the nanoRaman project, Raman spectroscopy is combined with so-called photonic nanojets, which can focus light with extreme precision. The aim is to create a form of super-resolution Raman microscopy that allows researchers to detect chemical and structural details in biological samples that are normally difficult to detect with traditional microscopes.
About the project: nanoRaman (Next-gen biomedical imaging: Nano super-resolution Raman microscope)
Grant amount: DKK 20,905,760 from Innovation Fund Denmark, Grand Solutions. Of this, DKK 3.5 million is allocated to the University of Southern Denmark and DKK 3.5 million to Odense University Hospital.
Project partners:
DFM – Danish Fundamental Metrology under DTU is leading the project and will develop the theoretical foundation for the technology as well as methods for validating nanoRaman.
SPIO Systems is responsible for the nano-optical solutions, Lightnovo is working to translate the technology into a product, and the University of Southern Denmark contributes advanced microscopy and artificial intelligence.
Odense University Hospital and veterinary researchers from Aarhus University and the University of Copenhagen will ensure that the platform is tested and validated on real clinical and veterinary samples.
Project period: 4 years - starting March 1st, 2026
Purpose: To develop a diagnostic tool that can identify infections, antibiotic resistance and signs of disease faster and more precisely than is possible today – and without the use of dyes or chemical markers.
Read also:
Read more at Innovation Fund Denmark
Meet the researcher
Thomas Emil Andersen, professor of medical microbiology at the Department of Clinical Research and Odense University Hospital. Thomas Emil Andersen’s group is responsible for testing the technology on clinical samples.
Meet the researcher
Jonathan Brewer, professor at the Department of Biochemistry and Molecular Biology. Jonathan Brewer’s group is responsible for the microscopy.